Xacduro Kit
Product Images NDC 68547-111

Product Visual Gallery

This gallery contains 37 technical images submitted to the FDA as part of the official labeling for Xacduro (NDC 68547-111). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by La Jolla Pharmaceutical Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Xacduro 01)

Chemical structure of sulbactam, one of the active ingredients in Xacduro (sulbactam and durlobactam) kit by La Jolla Pharmaceutical Company.*

FDA Label Image

Figure 2 (Xacduro 02)

Chemical structure of durlobactam, an active ingredient in Xacduro (sulbactam and durlobactam). The diagram shows molecular bonds and functional groups, including amide, sulfonate, and sodium ion components.*

FDA Label Image

Image (Xacduro 03)

Xacduro kit packaging label showing a cylindrical container with a white body, a teal cap, and a white label area. The label is blank without visible text or markings. The product is by La Jolla Pharmaceutical Company and combines sulbactam and durlobactam as active ingredients.*

FDA Label Image

Image (Xacduro 04)

Xacduro kit by La Jolla Pharmaceutical Company shown as a single vial with a blank beige label and green cap, containing sulbactam and durlobactam. The image represents the drug's dosage form as a vial within the kit packaging.*

FDA Label Image

Image (Xacduro 05)

Xacduro kit by La Jolla Pharmaceutical Company consisting of a clear glass vial with a white cap and an opaque blank label. The vial appears to contain a white powder or solid, consistent with a prescription drug dosage form for reconstitution or mixing before administration.*

FDA Label Image

Image (Xacduro 06)

Xacduro kit includes two separate vials with blue caps. Both vials are unlabeled, with one vial slightly larger than the other. The kit is associated with the active ingredients sulbactam and durlobactam and is labeled by La Jolla Pharmaceutical Company.*

FDA Label Image

Image (Xacduro 07)

Xacduro kit in a clear glass vial with a white label and gray cap. The vial contains a beige powder. The label has black text, including the product name and manufacturing details, though specifics are not fully legible in the image. Labeled by La Jolla Pharmaceutical Company.*

FDA Label Image

Image (Xacduro 08)

The image shows a single medical infusion bag with measurement markings on its front side. The bag is rectangular with a hanging strap at the top and an outlet port at the bottom for fluid administration. There is no visible branding or text on the bag itself.*

FDA Label Image

Image (Xacduro 09)

Xacduro kit packaging label from La Jolla Pharmaceutical Company for human prescription drug. The label displays the proprietary name Xacduro prominently and indicates the active ingredients sulbactam and durlobactam. The product is identified as a kit, suitable for prescription use.*

FDA Label Image

Image (Xacduro 10)

Xacduro is presented as a clear vial with a white label and white cap. The vial appears empty or filled with a clear liquid, suitable for a kit dosage form. The image does not show text or dosage strength details. Labeler information is not visible on the vial label.*

FDA Label Image

Image (Xacduro 11)

An illustration of a syringe with volume markings. The syringe is depicted upright, with a plunger and needle attached. No text or branding is visible on the syringe.*

FDA Label Image

Image (Xacduro 12)

An instructional illustration showing hands being washed under running water, with soap bubbles visible, indicating the step of hand washing.*

FDA Label Image

Image (Xacduro 13)

Xacduro kit includes three clear glass vials with distinct colored caps: one with a teal cap, a second with a green cap, and a third with a white cap. The kit is a human prescription drug containing sulbactam and durlobactam, labeled by La Jolla Pharmaceutical Company.*

FDA Label Image

Image (Xacduro 14)

Illustration showing an intravenous (IV) fluid bag with volume markings and a connected IV line, representing the administration setup for a drug or fluid infusion.*

FDA Label Image

Image (Xacduro 15)

Xacduro kit vial shown as a clear glass container with no visible label text or markings. The vial has a white cap and contains a clear liquid. The image represents the dosage form for the combination drug sulbactam and durlobactam, marketed by La Jolla Pharmaceutical Company.*

FDA Label Image

Image (Xacduro 16)

Illustration showing a hand holding a vial with a blank label and a tablet or cap being held above it, likely depicting the vial and tablet from the Xacduro kit by La Jolla Pharmaceutical Company.*

FDA Label Image

Image (Xacduro 17)

An illustration showing a vial held by one hand and a syringe or container being used by the other hand to add or withdraw from the vial. The vial has a blank label, and both hands are wearing gloves, suggesting sterile handling of medication.*

FDA Label Image

Image (Xacduro 18)

An instructional illustration showing two hands preparing a medication pouch or bag, with one hand holding the pouch and the other hand manipulating a small segment or cap on the pouch. No text or branding is visible.*

FDA Label Image

Image (Xacduro 19)

Xacduro kit consisting of two small glass vials with blue flip-off caps and white labels. The kit contains the sulbactam and durlobactam components as indicated by the product data, manufactured by La Jolla Pharmaceutical Company.*

FDA Label Image

Image (Xacduro 20)

An instructional illustration showing a syringe aligned above a vial with a downward arrow, indicating the action of inserting the syringe needle into the vial for drawing medication. A hand is holding the vial steady at the neck.*

FDA Label Image

Image (Xacduro 21)

Instructional illustration showing a hand holding a vial being inverted into another vial with arrows indicating the motion. The text advises to gently invert the vials 3 to 5 times. This is part of preparation instructions for the Xacduro kit by La Jolla Pharmaceutical Company containing sulbactam and durlobactam.*

FDA Label Image

Image (Xacduro 22)

Illustration showing a hand inverting a vial and withdrawing liquid into a syringe, with the text 'Invert and withdraw' and a downward arrow indicating the motion. This is an instructional diagram likely related to the preparation of the Xacduro (sulbactam and durlobactam) kit.*

FDA Label Image

Image (Xacduro 23)

An instructional illustration showing a hand holding a vial being injected with a syringe to withdraw 2.5 mL of liquid. The markup emphasizes the 2.5 mL volume to be drawn, likely as part of drug preparation instructions.*

FDA Label Image

Image (Xacduro 24)

Instructional illustration showing a vial with the text 'Repeat Step 3 with second durlobactam vial' arranged inside a circle with arrows, indicating a repeated step in a process involving durlobactam.*

FDA Label Image

Image (Xacduro 25)

The image shows a clear glass vial with a white cap and an opaque white label area, typically used for injectable drugs. The vial contains a powder or solid medication. No text or detailed labeling is visible on the vial in the image.*

FDA Label Image

Image (Xacduro 26)

An instructional illustration showing a hand holding a vial while a syringe needle is being inserted into the vial's rubber stopper, with a downward arrow indicating the action of inserting the needle. This image likely demonstrates how to withdraw medication from the vial.*

FDA Label Image

Image (Xacduro 27)

An instructional illustration showing a hand holding a small vial above a bottle, with curved arrows indicating to gently invert the vial and bottle 3 to 5 times. The text below states 'Gently invert 3-5 times.' This visual likely demonstrates a preparation step for the Xacduro kit.*

FDA Label Image

Image (Xacduro 28)

An instructional illustration showing a hand holding a vial upside down over a syringe with the text 'Invert and withdraw' and a downward arrow, indicating the step to invert the vial and withdraw the liquid into the syringe. This is related to preparation instructions for a drug kit.*

FDA Label Image

Image (Xacduro 29)

An instructional illustration showing the preparation of an injection. It depicts a hand holding a vial or bag labeled to inject 5 mL, with a syringe drawing fluid from the container. The image is likely intended to guide proper drug reconstitution or administration steps for a kit dosage form.*

FDA Label Image

Image (Xacduro 30)

Instructional illustration showing an infusion bag with arrows indicating a gentle inversion motion. Below the image, the text reads 'Gently invert infusion bag.' This diagram visually guides how to handle the infusion bag properly.*

FDA Label Image

Image (Xacduro 31)

Xacduro kit packaging label showing an opened white storage container with a barcode label inside. The kit is for the human prescription drug containing sulbactam and durlobactam, labeled by La Jolla Pharmaceutical Company.*

FDA Label Image

Image (Xacduro 32)

Illustration showing an intravenous (IV) bag with fluid, accompanied by a circular graphic stating 'within 24 hours,' indicating a recommended time frame related to the product's use or administration.*

FDA Label Image

Image (Xacduro 33)

An instructional illustration showing a vial or syringe being disposed of into a waste container labeled with a biohazard symbol, indicated by a downward arrow to emphasize proper disposal.*

FDA Label Image

Principal Display Panel (Kit Carton)

Xacduro single-dose kit contains sulbactam and durlobactam for injection, co-packaged for intravenous use. The kit includes two amber vials of durlobactam 0.5 g each and one clear vial of sulbactam 1 g. Distributed by La Jolla Pharmaceutical Company, it is labeled for sterile use and intravenous infusion after dilution.*

FDA Label Image

Principal Display Panel (0.5 g Vial Label)

Label for Xacduro kit vial showing Durlobactam 0.5 g per vial for injection, indicated for use with Sulbactam. It specifies intravenous infusion after dilution, single-dose vial, and storage at 2°C to 8°C. Distributed by La Jolla Pharmaceutical Company, with barcodes and sterile, Rx-only notation.*

FDA Label Image

Principal Display Panel (0.5 g Vial Label)

Label for Durlobactam injection 0.5 g per vial, part of the Xacduro kit. This is vial 2 of 3 and must be administered with Sulbactam. Instructions indicate reconstitution with 2.5 mL sterile water for injection. Distributed by La Jolla Pharmaceutical Company. The label also includes storage instructions and a barcode.*

FDA Label Image

Principal Display Panel (1 g Vial Label)

Label for Xacduro kit vial containing Sulbactam 1 g for injection, part 3 of 3 vials. The label states it must be administered with Durlobactam, for intravenous infusion after dilution. Distributed by La Jolla Pharmaceutical Company, with storage instructions and barcodes visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.